TXMD is currently covered by 3 analysts with average potential upside of $244.92 (101.75%) backed by 58 price targets and 68 ratings. Documented since 01-Nov-2013. Analyst's average stock valuation to be materialised ratio is 22.18% with an average time for price targets to be met of 103 days.
Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 11-Jan-2023.
Highest price target for TXMD is 47, Lowest price target is 3, average price target is 25.
Currently, out of the existing stock ratings of TXMD - 2 which are a Buy (40%), 3 which are a Hold (60%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
5
$1.28 (34.41%)
1
2 months 17 days ago
1/3 (33.33%)
$-2.07 (-49.16%)
29
Buy
10
$6.28 (168.82%)
9 months 21 days ago
1/2 (50%)
$81.54 (43.94%)
28
Buy
250
$246.28 (6620.43%)
450
1 years 7 months 23 days ago
0/6 (0%)
$402.73 (227.33%)
Sell
150
2 years 7 months 21 days ago
2/3 (66.67%)
$161 (41.64%)
83
Buy
2 years 11 months 12 days ago
1/19 (5.26%)
$616.84 (272.28%)
581
What is TXMD(TherapeuticsMD, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on TXMD(TherapeuticsMD, Inc) with a proven track record?
